- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Merck & Co. (Rahway, NJ)
- …external device designers, developers, and suppliers for selected device technology platforms .Oversee and serve as a technical integrator of all device development ... activities including engineering design, engineering analysis and testing, medical device design controls, risk management, test method/fixture development, design verification and validation, injection molding, automated assembly, and human factors… more
- BioAgilytix (Durham, NC)
- …SkillsAbility to develop immunoassays in some or all of the following platforms : ELISA, MSD-ECL, RIA, DELFIA, HTRF, and AlphaScreenExperience in AAV/gene therapy ... (preferred)Work effectively within team to meet objectives under time constraintsAbility to perform under stress and multi-taskDetail oriented and highly organizedExcellent oral and written communication skillsProficient in the use of MS Excel and… more
- Merck & Co. (South San Francisco, CA)
- …of the strategic plan within CMD, including integration of new technology platforms , human biology, data science, while focusing on uncovering novel biology that ... delivers high-quality drug discovery pipeline.-We are a research-driven biopharmaceutical company. -Our mission is built on the simple premise that if we "follow the science" and that great medicines can make a significant impact to our world.- We believe that… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- ALPCO (CA)
- …needs, implement customized solutions, and ensure rapid adoption of ALPCO platforms .This position requires strong technical skills, a solid background in life ... sciences, and the ability to communicate complex information clearly to both technical and scientific audiences. Significant travel is required to install and maintain instrumentation, provide scientific applications support, train customers, and ensure… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
